vimarsana.com

Page 4 - மருத்துவ சோதனைகள் ஆம்ப் மருத்துவ கண்டுபிடிப்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SpliSense Presents Preclinical Data for SPL23-ASO, mRNA-Altering Drug Candidate for the Treatment of Cystic Fibrosis, at the European Cystic Fibrosis Conference

/PRNewswire/ SpliSense, a biopharmaceutical company developing transformative mRNA-altering therapies for cystic fibrosis (CF) and other pulmonary diseases,.

Israel generalTsipi haitovskyGili hartHebrew university of jerusalemCystic fibrosis transmembraneBatsheva keremHebrew universityChief scientific officerEuropean cystic fibrosis digital conferenceMedical pharmaceuticalsHealth care amp hospitalsClinical trials amp medical discoveriesNew products amp servicesஇஸ்ரேல் ஜநரல்ஹீப்ரு பல்கலைக்கழகம் ஆஃப் ஏருசலேம்ஹீப்ரு பல்கலைக்கழகம்

Curis Announces Positive Updated Data from Ongoing Phase 1/2 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes

/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today.

United statesJames dentzerGuillermo garcia maneroUniversity of texas md anderson cancer centerDrug administrationEuropean hematology associationCuris incExchange commissionPrnewswire curis incDepartment of leukemiaRoche groupVirtual congressChief executive officerMyelodysplastic syndromesCancer centerRecommended phase

Stuart Therapeutics Announces Start of Patient Enrollment in its Phase 2 Clinical Trial of ST-100 for Dry Eye Disease

/PRNewswire/ Stuart Therapeutics, Inc. ("Stuart"), a clinical stage biopharmaceutical company conducting research and development of unique peptide.

United statesUnited kingdomGeorge ouslerEric schlumpfRobert barattaCora incStuart therapeutics incPrnewswire stuart therapeutics incDry eye eiseaseDry eye diseaseStuart therapeuticsSenior vice presidentChief medical officerHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveries

European Hematology Association - Restoration of T Helper Cell Imbalance in Immune Thrombocytopenia by β2-Adrenergic Receptor Agonists

/PRNewswire/ Immune thrombocytopenia (ITP) is a disease manifesting as a low platelet count in which dysregulation of T helper (Th) cells play a central.

Xiao hui zhangEuropean hematology associationUniversity people hospitalProfessor zhangProfessor xiao huiPeking university peopleEvery juneAnnual congressHematology associationEuropean hematology association ehaHealth care amp hospitalsMedical equipmentMedical pharmaceuticalsClinical trials amp medical discoveriesNew products amp servicesஐரோப்பிய ஹீமாட்டாலஜி சங்கம்

European Hematology Association - Clinical Trial Efficacy of CAR-T Therapy in Patients with Diffuse Large B-cell Lymphoma Is Mirrored in the Real World

/PRNewswire/ DESCAR-T is the French national registry for patients treated with commercial chimeric antigen receptor (CAR)-T cells across all hematological.

Steven le gouillEuropean hematology associationProfessor steven le gouillEvery juneAnnual congressHematology associationEuropean hematology association ehaHealth care amp hospitalsMedical equipmentMedical pharmaceuticalsClinical trials amp medical discoveriesNew products amp servicesஐரோப்பிய ஹீமாட்டாலஜி சங்கம்ஒவ்வொன்றும் ஜூன்ஆண்டு காங்கிரஸ்ஹீமாட்டாலஜி சங்கம்

vimarsana © 2020. All Rights Reserved.